Literature DB >> 10852086

Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes.

J L DiGiacinto1, K M Olsen, K L Bergman, E B Hoie.   

Abstract

OBJECTIVE: To determine the stability of lansoprazole and omeprazole suspensions at ambient and refrigerated temperatures using HPLC.
DESIGN: The contents of lansoprazole and omeprazole capsules were suspended in separate flasks containing sodium bicarbonate 8.4% to concentrations of 3 and 2 mg/mL, respectively. The contents of each flask were drawn into six amber-colored oral syringes, with one-half of the syringes stored at 22 degrees C (ambient) and the other half at 4 degrees C. Lansoprazole and omeprazole concentrations were determined by a stability-indicating HPLC assay at baseline and at 4, 8, 12, and 24 hours, and on days 4, 7, 14, 21, 30, 45, and 60 after mixing. Both omeprazole and lansoprazole were considered stable if they retained > or =90% of the baseline drug concentration.
RESULTS: Omeprazole was stable for up to 14 days at 22 degrees C and 45 days at 4 degrees C. Lansoprazole was stable for eight hours at 22 degrees C and for 14 days at 4 degrees C.
CONCLUSIONS: When compared with ambient or refrigerated storage conditions, omeprazole was stable for a longer duration than lansoprazole. Pharmacists may use these results to guide compounding and storage of proton-pump inhibitor suspensions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852086     DOI: 10.1345/aph.19086

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  6 in total

1.  Stability of extemporaneously prepared lansoprazole suspension at two temperatures.

Authors:  Jordan T Morrison; Ralph A Lugo; Jim C Thigpen; Stacy D Brown
Journal:  J Pediatr Pharmacol Ther       Date:  2013-04

2.  A Critical Assessment of Extemporaneous Formulations for Proton Pump Inhibitors: The Importance of Proper Vehicle Selection.

Authors:  Ognjenka Rahić; Jasmina Hadžiabdić; Amina Tucak; Merima Sirbubalo; Lamija Hindija; Alisa Elezović; Edina Vranić
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

3.  Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.

Authors:  Hudson C Polonini; Sharlene L Silva; Shirley Loures; Rachel Almy; Antoine Balland; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-11-25

4.  Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry.

Authors:  Stacy D Brown; Justin D Connor; Nicholas C Smallwood; Ralph A Lugo
Journal:  Int J Anal Chem       Date:  2011-06-22       Impact factor: 1.885

5.  Carers' experiences of home enteral feeding: A survey exploring medicines administration challenges and strategies.

Authors:  D Alsaeed; D Furniss; A Blandford; F Smith; M Orlu
Journal:  J Clin Pharm Ther       Date:  2018-01-19       Impact factor: 2.512

6.  Serum concentrations of gastrin after famotidine and omeprazole administration to dogs.

Authors:  N L Parente; N Bari Olivier; K R Refsal; C A Johnson
Journal:  J Vet Intern Med       Date:  2014-07-23       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.